{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Chalcone", "anticancer", "synthesis", "tubulin inhibitor"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "31724435", "DateCompleted": {"Year": "2020", "Month": "01", "Day": "13"}, "DateRevised": {"Year": "2021", "Month": "05", "Day": "07"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": ["10.1080/14756366.2019.1690479"], "Journal": {"ISSN": "1475-6374", "JournalIssue": {"Volume": "35", "Issue": "1", "PubDate": {"Year": "2020", "Month": "Dec"}}, "Title": "Journal of enzyme inhibition and medicinal chemistry", "ISOAbbreviation": "J Enzyme Inhib Med Chem"}, "ArticleTitle": "Synthesis, biological evaluation, and molecular modelling of new naphthalene-chalcone derivatives as potential anticancer agents on MCF-7 breast cancer cells by targeting tubulin colchicine binding site.", "Pagination": {"StartPage": "139", "EndPage": "144", "MedlinePgn": "139-144"}, "Abstract": {"AbstractText": ["A series of naphthalene-chalcone derivatives (<b>3a-3t</b>) were prepared and evaluated as tubulin polymerisation inhibitor for the treatment of breast cancer. All compounds were evaluated for their antiproliferative activity against MCF-7 cell line. The most of compounds displayed potent antiproliferative activity. Among them, compound <b>3a</b> displayed the most potent antiproliferative activity with an IC<sub>50</sub> value of 1.42\u2009\u00b1\u20090.15\u2009\u00b5M, as compared to cisplatin (IC<sub>50</sub>\u2009=\u200915.24\u2009\u00b1\u20091.27\u2009\u00b5M). Additionally, the promising compound <b>3a</b> demonstrated relatively lower cytotoxicity on normal cell line (HEK293) compared to tumour cell line. Furthermore, compound <b>3a</b> was found to induce significant cell cycle arrest at the G<sub>2</sub>/M phase and cell apoptosis. Compound <b>3a</b> displayed potent tubulin polymerisation inhibitory activity with an IC<sub>50</sub> value of 8.4\u202f\u00b5M, which was slightly more active than the reference compound colchicine (IC<sub>50</sub>\u202f=\u202f10.6\u2009\u00b5M). Molecular docking analysis suggested that <b>3a</b> interact and bind at the colchicine binding site of the tubulin."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Provincial Key Laboratory of Pharmaceutics, Guizhou Medical University, Guiyang, China."}, {"Identifier": [], "Affiliation": "College of Chemistry and Chemical Engineering, Jishou University, Jishou, China."}], "LastName": "Wang", "ForeName": "Guangcheng", "Initials": "G"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Engineering Research Center for the Development and Application of Ethnic Medicine and TCM (Ministry of Education), Guizhou Medical University, Guiyang, China."}, {"Identifier": [], "Affiliation": "School of Pharmacy, Guizhou Medical University, Guiyang, China."}], "LastName": "Liu", "ForeName": "Wenjing", "Initials": "W"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Provincial Key Laboratory of Pharmaceutics, Guizhou Medical University, Guiyang, China."}], "LastName": "Gong", "ForeName": "Zipeng", "Initials": "Z"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Provincial Key Laboratory of Pharmaceutics, Guizhou Medical University, Guiyang, China."}], "LastName": "Huang", "ForeName": "Yong", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Engineering Research Center for the Development and Application of Ethnic Medicine and TCM (Ministry of Education), Guizhou Medical University, Guiyang, China."}], "LastName": "Li", "ForeName": "Yongjun", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Chemistry and Chemical Engineering, Jishou University, Jishou, China."}, {"Identifier": [], "Affiliation": "College of Food Science and Technology, Shanghai Ocean University, Shanghai, China."}], "LastName": "Peng", "ForeName": "Zhiyun", "Initials": "Z"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "J Enzyme Inhib Med Chem", "NlmUniqueID": "101150203", "ISSNLinking": "1475-6366"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Chalcones"}, {"RegistryNumber": "0", "NameOfSubstance": "Naphthalenes"}, {"RegistryNumber": "0", "NameOfSubstance": "Tubulin"}, {"RegistryNumber": "0", "NameOfSubstance": "Tubulin Modulators"}, {"RegistryNumber": "SML2Y3J35T", "NameOfSubstance": "Colchicine"}], "MeshHeadingList": [{"QualifierName": ["chemical synthesis", "chemistry", "pharmacology"], "DescriptorName": "Antineoplastic Agents"}, {"QualifierName": ["drug effects"], "DescriptorName": "Apoptosis"}, {"QualifierName": ["drug effects"], "DescriptorName": "Binding Sites"}, {"QualifierName": ["drug therapy", "metabolism", "pathology"], "DescriptorName": "Breast Neoplasms"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Cycle Checkpoints"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Proliferation"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Chalcones"}, {"QualifierName": ["antagonists & inhibitors", "metabolism"], "DescriptorName": "Colchicine"}, {"QualifierName": [], "DescriptorName": "Dose-Response Relationship, Drug"}, {"QualifierName": [], "DescriptorName": "Drug Screening Assays, Antitumor"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "MCF-7 Cells"}, {"QualifierName": [], "DescriptorName": "Models, Molecular"}, {"QualifierName": [], "DescriptorName": "Molecular Structure"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Naphthalenes"}, {"QualifierName": [], "DescriptorName": "Structure-Activity Relationship"}, {"QualifierName": ["metabolism"], "DescriptorName": "Tubulin"}, {"QualifierName": ["chemical synthesis", "chemistry", "pharmacology"], "DescriptorName": "Tubulin Modulators"}], "CoiStatement": "No potential conflict of interest was reported by the authors."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Jordan MA, Wilson L.. Microtubules as a target for anticancer drugs. Nat Rev Cancer 2004;4:253\u201365.", "ArticleIdList": ["15057285"]}, {"Citation": "Dumontet C, Jordan MA.. Microtubule-binding agents: a dynamic field of cancer therapeutics. Nat Rev Drug Discov 2010;9:790\u2013803.", "ArticleIdList": ["PMC3194401", "20885410"]}, {"Citation": "Kaur R, Kaur G, Gill RK, et al. . Recent developments in tubulin polymerization inhibitors: an overview. Eur J Med Chem 2014;87:89\u2013124.", "ArticleIdList": ["25240869"]}, {"Citation": "Li Q, Sham HL.. Discovery and development of antimitotic agents that inhibit tubulin polymerisation for the treatment of cancer. Expert Opin Ther Pat 2002;12:1663\u2013702."}, {"Citation": "Shi Q, Chen K, Morris-Natschke SL, Lee KH.. Recent progress in the development of tubulin inhibitors as antimitotic antitumor agents. Curr Pharm Des 1998;4:219\u201348.", "ArticleIdList": ["10197041"]}, {"Citation": "Jordan A, Hadfield JA, Lawrence NJ, McGown AT.. Tubulin as a target for anticancer drugs: agents which interact with the mitotic spindle. Med Res Rev 1998;18:259\u201396.", "ArticleIdList": ["9664292"]}, {"Citation": "Bukhari SNA, Jasamai M, Jantan I.. Synthesis and biological evaluation of chalcone derivatives (mini review). Mini Rev Med Chem 2012;12:1394\u2013403.", "ArticleIdList": ["22876958"]}, {"Citation": "Gomes MN, Muratov EN, Pereira M, et al. . Chalcone derivatives: promising starting points for drug design. Molecules 2017;22:1210.", "ArticleIdList": ["PMC6152227", "28757583"]}, {"Citation": "Zhuang CL, Zhang W, Sheng CQ, et al. . Chalcone: a privileged structure in medicinal chemistry. Chem Rev 2017;117:7762\u2013810.", "ArticleIdList": ["PMC6131713", "28488435"]}, {"Citation": "Mirzaei H, Emami S.. Recent advances of cytotoxic chalconoids targeting tubulin polymerization: synthesis and biological activity. Eur J Med Chem 2016;121:610\u201339.", "ArticleIdList": ["27318983"]}, {"Citation": "Mahapatra DM, Bharti SK, Asati V.. Anti-cancer chalcones: structural and molecular target perspectives. Eur J Med Chem 2015;98:69\u2013114.", "ArticleIdList": ["26005917"]}, {"Citation": "Sharma R, Kumar R, Kodwani R, et al. . A review on mechanisms of anti tumor activity of chalcones. Anticancer Agents Med Chem 2015;16:200\u201311.", "ArticleIdList": ["25980813"]}, {"Citation": "Loa J, Chow P, Zhang K.. Studies of structure-activity relationship on plant polyphenol-induced suppression of human liver cancer cells. Cancer Chemother Pharmacol 2009;63:1007\u201316.", "ArticleIdList": ["18766342"]}, {"Citation": "Lee JM, Lee MS, Koh D, et al. . A new synthetic 2\u2032-hydroxy-2,4,6-trimethoxy-5\u2032,6\u2032-naphthochalcone induces g2/m cell cycle arrest and apoptosis by disrupting the microtubular network of human colon cancer cells. Cancer Lett 2014;354:348\u201354.", "ArticleIdList": ["25193463"]}, {"Citation": "Pouget C, Lauthier F, Simon A, et al. . Flavonoids: structural requirements for antiproliferative activity on breast cancer cells. Bioorg Med Chem Lett 2001;11:3095\u20137.", "ArticleIdList": ["11720850"]}, {"Citation": "Shin SY, Kim JH, Yoon H, et al. . Novel antimitotic activity of 2-hydroxy-4-methoxy-2\u2032,3\u2032-benzochalcone (hymnpro) through the inhibition of tubulin polymerization. J Agric Food Chem 2013;61:12588\u201397.", "ArticleIdList": ["24308485"]}, {"Citation": "Singh P, Raj R, Kumar V, et al. . 1,2,3-triazole tethered beta-lactam-chalcone bifunctional hybrids: synthesis and anticancer evaluation. Eur J Med Chem 2012;47:594\u2013600.", "ArticleIdList": ["22071256"]}, {"Citation": "Li L, Jiang SB, Li XX, et al. . Recent advances in trimethoxyphenyl (tmp) based tubulin inhibitors targeting the colchicine binding site. Eur J Med Chem 2018;151:482\u201394.", "ArticleIdList": ["29649743"]}, {"Citation": "Lindamulage IK, Vu HY, Karthikeyan C, et al. . Novel quinolone chalcones targeting colchicine-binding pocket kill multidrug-resistant cancer cells by inhibiting tubulin activity and mrp1 function. Sci Rep 2017;7:10298.", "ArticleIdList": ["PMC5578999", "28860494"]}, {"Citation": "Konieczny MT, Bulakowska A, Pirska D, et al. . Influence of s-oxidation on cytotoxic activity of oxathiole-fused chalcones. Chem Biol Drug Des 2016;88:519\u201333.", "ArticleIdList": ["27198732"]}, {"Citation": "Konieczny MT, Bulakowska A, Polak J, et al. . Structural factors affecting cytotoxic activity of (e)-1-(benzo d 1,3 oxathiol-6-yl)-3-phenylprop-2-en-1-one derivatives. Chem Biol Drug Des 2014;84:86\u201391.", "ArticleIdList": ["24476543"]}, {"Citation": "Tu HY, Huang AM, Hour TC, et al. . Synthesis and biological evaluation of 2\u2032,5\u2032-dimethoxychalcone derivatives as microtubule-targeted anticancer agents. Bioorg Med Chem 2010;18:2089\u201398.", "ArticleIdList": ["20199865"]}, {"Citation": "Konieczny MT, Bu\u026cakowska A, Pirska D, et al. . Structural factors affecting affinity of cytotoxic oxathiole-fused chalcones toward tubulin. Eur J Med Chem 2015;89:733\u201342.", "ArticleIdList": ["25462279"]}, {"Citation": "Ji YT, Liu YN, Liu ZP.. Tubulin colchicine binding site inhibitors as vascular disrupting agents in clinical developments. Curr Med Chem 2015;22:1348\u201360.", "ArticleIdList": ["25620094"]}, {"Citation": "Zhou ZZ, Shi XD, Feng HF, et al. . Discovery of 9h-purins as potential tubulin polymerization inhibitors: synthesis, biological evaluation and structure activity relationships. Eur J Med Chem 2017;138:1126\u201334.", "ArticleIdList": ["28763647"]}, {"Citation": "Wang G, Li C, He L, et al. . Design, synthesis and biological evaluation of a series of pyrano chalcone derivatives containing indole moiety as novel anti-tubulin agents. Bioorg Med Chem 2014;22:2060\u201379.", "ArticleIdList": ["24629450"]}, {"Citation": "Ettari R, Pallio G, Pizzino G, et al. . Non-covalent immunoproteasome inhibitors induce cell cycle arrest in multiple myeloma mm.1r cells. J Enzyme Inhib Med Chem 2019;34:1307\u201313.", "ArticleIdList": ["PMC6691773", "31307247"]}, {"Citation": "Trott O, Olson AJ.. Software news and update autodock vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem 2010;31:455\u201361.", "ArticleIdList": ["PMC3041641", "19499576"]}]}], "History": [{"Year": "2019", "Month": "11", "Day": "15", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "11", "Day": "15", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "1", "Day": "14", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "11", "Day": "14"}], "PublicationStatus": "ppublish", "ArticleIdList": ["31724435", "PMC6882462", "10.1080/14756366.2019.1690479"]}}]}